172 related articles for article (PubMed ID: 35448191)
1. P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model.
Cruz-Morande S; Dotor J; San-Julian M
Curr Oncol; 2022 Apr; 29(4):2650-2661. PubMed ID: 35448191
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
Hermida N; López B; González A; Dotor J; Lasarte JJ; Sarobe P; Borrás-Cuesta F; Díez J
Cardiovasc Res; 2009 Feb; 81(3):601-9. PubMed ID: 19019833
[TBL] [Abstract][Full Text] [Related]
3. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis.
Santiago B; Gutierrez-Cañas I; Dotor J; Palao G; Lasarte JJ; Ruiz J; Prieto J; Borrás-Cuesta F; Pablos JL
J Invest Dermatol; 2005 Sep; 125(3):450-5. PubMed ID: 16117784
[TBL] [Abstract][Full Text] [Related]
4. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.
Li D; Zhang J; Yuan S; Wang C; Chang J; Tong Y; Liu R; Sang T; Li L; Li J; Ouyang Q; Chen X
Cell Prolif; 2022 Oct; 55(10):e13299. PubMed ID: 35762283
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.
Zarranz-Ventura J; Fernández-Robredo P; Recalde S; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
PLoS One; 2013; 8(5):e65434. PubMed ID: 23741494
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 inhibitor P144 protects against benign restenosis after esophageal stenting through TGF-β1/Smads signaling pathway inhibition.
Wu JZ; Zhou C; Liu S; Zhang JX; Yang W; Shi HB; Zhou WZ
Arab J Gastroenterol; 2024 May; 25(2):214-222. PubMed ID: 38369402
[TBL] [Abstract][Full Text] [Related]
8. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
9. Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue.
Schultze-Mosgau S; Blaese MA; Grabenbauer G; Wehrhan F; Kopp J; Amann K; Rodemann HP; Rödel F
Radiother Oncol; 2004 Mar; 70(3):249-59. PubMed ID: 15064009
[TBL] [Abstract][Full Text] [Related]
10. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
11. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
12. A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.
Ezquerro IJ; Lasarte JJ; Dotor J; Castilla-Cortázar I; Bustos M; Peñuelas I; Blanco G; Rodríguez C; Lechuga Mdel C; Greenwel P; Rojkind M; Prieto J; Borrás-Cuesta F
Cytokine; 2003 Apr; 22(1-2):12-20. PubMed ID: 12946101
[TBL] [Abstract][Full Text] [Related]
13. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
14. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.
Baltanás A; Miguel-Carrasco JL; San José G; Cebrián C; Moreno MU; Dotor J; Borrás-Cuesta F; López B; González A; Díez J; Fortuño A; Zalba G
Antioxid Redox Signal; 2013 Nov; 19(14):1607-18. PubMed ID: 23350688
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective study.
Boothe DL; Coplowitz S; Greenwood E; Barney CL; Christos PJ; Parashar B; Nori D; Chao KS; Wernicke AG
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1030-6. PubMed ID: 24139518
[TBL] [Abstract][Full Text] [Related]
18. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
[TBL] [Abstract][Full Text] [Related]
19. Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation.
Jiang X; Chen Y; Zhu H; Wang B; Qu P; Chen R; Sun X
PLoS One; 2015; 10(6):e0129655. PubMed ID: 26061047
[TBL] [Abstract][Full Text] [Related]
20. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
Yao Y; Chen R; Wang G; Zhang Y; Liu F
Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]